Related references
Note: Only part of the references are listed.Using the Common Terminology Criteria for Adverse Events (CTCAE - Version 5.0) to Evaluate the Severity of Adverse Events of Anticancer Therapies
A. Freites-Martinez et al.
ACTAS DERMO-SIFILIOGRAFICAS (2021)
Selumetinib in Children with Inoperable Plexiform Neurofibromas
Andrea M. Gross et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Selumetinib in Children with Inoperable Plexiform Neurofibromas (vol 382, pg 1430, 2020)
Andrea M. Gross et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform Neurofibromas
Eva Dombi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer
Alan L. Ho et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Share Paper
